Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental condition commonly diagnosed in childhood but often continuing into adulthood. It affects the brain’s executive functioning, impairing a person’s ability to regulate attention, impulses, and behavior. Individuals with ADHD may exhibit inattentiveness, hyperactivity, impulsiveness, or a combination of these behaviors. The severity and presentation vary from person to person and can significantly impact daily functioning, relationships, academic performance, and work productivity.
ADHD symptoms are grouped into two primary categories: inattention and hyperactivity/impulsivity. These symptoms must be chronic, pervasive, and inappropriate for the individual’s developmental level.
Diagnosing ADHD requires a comprehensive assessment that includes:
A detailed history of the patient’s symptoms, family background, educational and social performance, and medical history helps identify patterns consistent with ADHD.
Standardized rating scales from parents, teachers, and the individual provide objective information about symptoms across settings.
An FDA-approved, computerized assessment tool used to evaluate attention, impulsivity, and activity levels. The QB Check offers an objective measure to support a clinical diagnosis.
Treatment for ADHD is multifaceted and includes behavioral, pharmacological, and supportive interventions.
